MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-05-2026
Haemonetics Corporation DIO Ratio 2011-2026 | HAE
Annual DIO Ratio Haemonetics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 204 | 170 | 182 | 230 | 229 | 197 | 134 | 119 | 127 | 136 | 162 | 154 | 145 | 119 | 95.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 230 | 95.8 | 160 |
Quarterly DIO Ratio Haemonetics Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 220 | 240 | 256 | - | 218 | 218 | 196 | - | 170 | 178 | 174 | - | 159 | 174 | 219 | - | - | 252 | 125 | - | 230 | 228 | 248 | 227 | 174 | 163 | 151 | 135 | 111 | 114 | 118 | - | 122 | 129 | 134 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 256 | 111 | 181 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
213 | $ 70.29 | 0.17 % | $ 14 B |  USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
126 | $ 74.63 | 0.09 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Baxter International
BAX
|
99.3 | $ 16.65 | -0.18 % | $ 8.54 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | USA |
 |
BioLife Solutions
BLFS
|
457 | $ 19.27 | -1.23 % | $ 888 M | USA |
 |
AtriCure
ATRC
|
210 | $ 29.19 | 0.41 % | $ 1.39 B | USA |
 |
electroCore
ECOR
|
142 | $ 7.04 | 3.53 % | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
288 | $ 9.75 | 3.72 % | $ 23.7 M | USA |
 |
Glaukos Corporation
GKOS
|
193 | $ 116.69 | 3.48 % | $ 5.65 B | USA |
 |
Harvard Bioscience
HBIO
|
219 | $ 5.53 | 6.35 % | $ 245 M | USA |
 |
ICU Medical
ICUI
|
155 | $ 122.99 | -0.26 % | $ 3.03 B | USA |
 |
InfuSystem Holdings
INFU
|
33.8 | $ 9.43 | 1.51 % | $ 195 M | USA |
 |
iRhythm Technologies
IRTC
|
29.6 | $ 117.22 | 0.36 % | $ 3.75 B | USA |
 |
Isoray
ISR
|
94.7 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
177 | $ 452.58 | 0.11 % | $ 162 B | USA |
 |
Repro Med Systems
KRMD
|
76.2 | $ 4.26 | -1.39 % | $ 197 M | USA |
 |
LeMaitre Vascular
LMAT
|
338 | $ 109.16 | 0.62 % | $ 2.47 B | USA |
 |
Masimo Corporation
MASI
|
168 | $ 178.49 | -0.06 % | $ 9.51 B | USA |
 |
Milestone Scientific
MLSS
|
533 | $ 0.29 | 1.9 % | $ 23.8 M | USA |
 |
Merit Medical Systems
MMSI
|
150 | $ 67.81 | 0.16 % | $ 4.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
78.3 | $ 25.81 | - | $ 4.34 B | USA |
 |
Predictive Oncology
POAI
|
1.12 K | - | - | $ 31.1 M | USA |
 |
Pro-Dex
PDEX
|
145 | $ 48.53 | -6.08 % | $ 160 M | USA |
 |
Pulse Biosciences
PLSE
|
89 | $ 22.94 | -0.26 % | $ 1.55 B | USA |
 |
ResMed
RMD
|
141 | $ 224.93 | 0.37 % | $ 32.9 B | USA |
 |
Retractable Technologies
RVP
|
174 | $ 0.71 | 2.98 % | $ 21.3 M | USA |
 |
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | USA |
 |
STAAR Surgical Company
STAA
|
164 | $ 20.96 | 3.71 % | $ 1.04 B | USA |
 |
STERIS plc
STE
|
75 | $ 219.97 | 0.58 % | $ 21.7 B | USA |
 |
Stereotaxis
STXS
|
213 | $ 1.88 | -0.53 % | $ 171 M | USA |
 |
Teleflex Incorporated
TFX
|
149 | $ 115.04 | -2.35 % | $ 5.13 B | USA |
 |
Utah Medical Products
UTMD
|
185 | $ 62.93 | -0.3 % | $ 204 M | USA |
 |
West Pharmaceutical Services
WST
|
76 | $ 256.85 | 0.8 % | $ 18.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
120 | $ 11.64 | 0.09 % | $ 2.32 B | USA |
 |
AngioDynamics
ANGO
|
166 | $ 9.84 | -4.56 % | $ 402 M | USA |
 |
Becton, Dickinson and Company
BDX
|
119 | $ 155.32 | 0.52 % | $ 44.7 B | USA |
 |
Nephros
NEPH
|
176 | $ 2.86 | -0.35 % | $ 29.7 M | USA |
 |
OraSure Technologies
OSUR
|
178 | $ 3.08 | - | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
227 | $ 116.95 | -0.7 % | $ 6.52 M | USA |